We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M Turnover 23.21%
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+37.16%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$183M
AUM Growth
+$24.7M
Cap. Flow
-$21.5M
Cap. Flow %
-11.74%
Top 10 Hldgs %
60.99%
Holding
128
New
6
Increased
17
Reduced
11
Closed
35
Avg Time Held
3.1 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$7.51M
2
KW icon
Kennedy-Wilson Holdings
KW
+$3.02M
3
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$1.72M
4
ZGNX
Zogenix, Inc.
ZGNX
+$1.46M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$1.35M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$8.13M
2
BRSL icon
Brightstar Lottery PLC
BRSL
+$3.9M
3
APO icon
Apollo Global Management
APO
+$3.18M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.1M
5
FNM.PRT
FEDERAL NATL MTG ASS 08250
FNM.PRT
+$2.19M

Sector Composition

Rank Sector Weight
1 Healthcare 45.06%
2 Financials 16.44%
3 Industrials 13.2%
4 Technology 8.55%
5 Communication Services 5.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CHRS icon
26
Coherus Oncology
CHRS
$153M
$1.87M 1.02%
104,566
+37,527
+56% +$635K
2017 Q2
12 quarters
AUPH icon
27
Aurinia Pharmaceuticals
AUPH
$2.2B
$1.87M 1.02%
114,810
+107,510
+1,473% +$1.72M
2020 Q1
1 quarter
MPLX icon
28
MPLX
MPLX
$59B
$1.73M 0.94%
100,000
– –
2018 Q1
9 quarters
VKTX icon
29
Viking Therapeutics
VKTX
$3.2B
$1.57M 0.86%
218,102
– –
2017 Q4
10 quarters
CDTX icon
30
DELISTED
Cidara Therapeutics
CDTX
$1.5M 0.82%
20,353
+250
+1% +$16.2K
2019 Q2
4 quarters
AB icon
31
AllianceBernstein
AB
$3.21B
$1.38M 0.75%
50,500
– –
2013 Q2
28 quarters
COLL icon
32
Collegium Pharmaceutical
COLL
$755M
$1.21M 0.66%
69,051
+19,980
+41% +$391K
2019 Q4
2 quarters
ALKS icon
33
Alkermes
ALKS
$6.92B
$1.13M 0.62%
58,073
– –
2019 Q4
2 quarters
SBBP
34
DELISTED
Strongbridge Biopharma plc.
SBBP
$1.12M 0.61%
296,037
+114,237
+63% +$342K
2019 Q4
2 quarters
JNJ icon
35
Johnson & Johnson
JNJ
$616B
$1.02M 0.56%
7,280
– –
2013 Q2
28 quarters
VZ icon
36
Verizon
VZ
$186B
$1.01M 0.55%
18,311
– –
2014 Q2
24 quarters
QTNT
37
DELISTED
Quotient Limited Ordinary Shares
QTNT
$959K 0.52%
3,238
+677
+26% +$195K
2017 Q4
10 quarters
BRSL icon
38
Brightstar Lottery PLC
BRSL
$1.74B
$957K 0.52%
107,500
-500,000
-82% -$3.9M
2019 Q1
5 quarters
QURE icon
39
uniQure
QURE
$1.51B
$917K 0.5%
20,358
+6,138
+43% +$362K
2019 Q4
2 quarters
KMB icon
40
Kimberly-Clark
KMB
$35.1B
$848K 0.46%
6,000
– –
2017 Q3
11 quarters
MDLZ icon
41
Mondelez International
MDLZ
$81.6B
$813K 0.44%
15,900
– –
2013 Q2
28 quarters
T icon
42
AT&T
T
$161B
$667K 0.36%
29,194
– –
2014 Q2
24 quarters
DD icon
43
DuPont de Nemours
DD
$17.6B
$643K 0.35%
9,654
– –
2015 Q1
21 quarters
KO icon
44
Coca-Cola
KO
$404B
$599K 0.33%
13,400
– –
2013 Q2
28 quarters
RDUS icon
45
DELISTED
Radius Health, Inc.
RDUS
$587K 0.32%
43,034
– –
2018 Q3
7 quarters
ADMA icon
46
ADMA Biologics
ADMA
$2.39B
$586K 0.32%
200,157
+59,400
+42% +$171K
2020 Q1
1 quarter
CNQ icon
47
Canadian Natural Resources
CNQ
$111B
$559K 0.31%
65,415
– –
2017 Q2
12 quarters
IBM icon
48
IBM
IBM
$219B
$517K 0.28%
4,481
– –
2015 Q1
21 quarters
ALIM icon
49
DELISTED
Alimera Sciences
ALIM
$505K 0.28%
80,194
+5,000
+7% +$26.1K
2017 Q3
11 quarters
DOW icon
50
Dow Inc
DOW
$21.6B
$494K 0.27%
12,118
– –
2019 Q2
4 quarters
1
2
3 4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q2 2020 Portfolio in Review

As of Q2 2020, David M. Knott held 128 positions worth $183M, up 16% from $158M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

David M. Knott withdrew a net $21.5M in Q2 2020, closing 35 positions and reducing 11 holdings. Its most notable exit was FEDERAL NATL MTG ASS 08250, an estimated $2.19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 41% a quarter earlier, followed by Financials and Industrials.

Against the trend, David M. Knott opened a new position in FTAI Aviation worth $9.09M.

  • David M. Knott's largest Q2 2020 buy was FTAI Aviation: 819,700 shares worth $9.09M.
  • David M. Knott added most to Aurinia Pharmaceuticals in Q2 2020, an estimated $1.72M increase.
  • David M. Knott's biggest Q2 2020 reduction was Ligand Pharmaceuticals, cutting an estimated $8.13M.
  • David M. Knott fully exited FEDERAL NATL MTG ASS 08250 in Q2 2020, selling an estimated $2.19M.
  • David M. Knott's ten largest holdings make up 61% of its $183M portfolio in Q2 2020.
  • David M. Knott opened 6 new positions and closed 35 in Q2 2020.
  • David M. Knott's portfolio value rose 16% quarter-over-quarter to $183M.

Based on David M. Knott's 13F filing for Q2 2020, filed 12 Aug 2020.